CHRISTINE SPRINGER: Open Payments
NPI 1871969220 · LEO, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,618 in 145 payments from 19 companies in 2025. Trend: 2023 $2,241 · 2024 $2,829 · 2025 $2,618
Food & beverage: $2,511Education: $107
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 19 | $692 |
| ABBVIE INC. | 29 | $389 |
| Axsome Therapeutics, Inc. | 9 | $235 |
| Corium, LLC | 17 | $202 |
| PFIZER INC. | 15 | $191 |
| Vanda Pharmaceuticals Inc. | 15 | $144 |
| Amgen Inc. | 8 | $137 |
| Novo Nordisk Inc | 5 | $103 |
| Sumitomo Pharma America, Inc. | 4 | $86 |
| Abbott Laboratories | 4 | $66 |
Products named: AIRSUPRA, Auvelity, BREZTRI, Azstarys, VRAYLAR, UBRELVY, QULIPTA, FANAPT.
Industry payments across IN — which companies pay providers there.
